Merck Reduces Workforce Globally while Building in China

Merck announced it will be cutting another 13,000 jobs, about 14% of its current headcount, while at the same time continuing to build its China workforce. About 35%-40% of the cutbacks will be in the US, especially in administrative and support personnel. Meanwhile, Merck reported China revenues rose in Q2 by 30% to $208 million, driven mainly by its products in the infectious disease and respiratory sectors. More details.... Stock Symbol: (NYSE: MRK)     Share this with colleagues: